Particle.news
Download on the App Store

ACOG Backs Partner Treatment in New Guidance for Recurrent Bacterial Vaginosis

The shift follows studies linking penile microbial communities to recurrence risk.

Overview

  • Clinicians are advised to consider treating male partners at the same time using an oral antibiotic plus a topical antimicrobial.
  • The recommendation targets adult patients experiencing recurrent, symptomatic bacterial vaginosis.
  • ACOG cites new supporting data after earlier research did not show clear benefit from partner treatment.
  • The guidance urges shared decision-making and highlights evidence gaps for nonmonogamous relationships, asymptomatic cases, and same-sex partners.
  • Bacterial vaginosis affects roughly 23% to 30% of women of reproductive age globally and can recur in up to 66% within a year as it reflects a vaginal microbiota imbalance rather than a single-pathogen infection.